Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $3 | $4 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $2 | $3 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 234% | 335.3% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.7% | 48.8% | 43.7% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -80.9% | -218.1% | -955% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -97.8% | -275.7% | -1,157.8% | – |
| EPS Diluted | -0.25 | -0.22 | -0.21 | -0.34 |
| % Growth | -13.6% | -4.8% | 38.2% | – |
| Operating Cash Flow | -$0 | $1 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $1 | -$0 | -$0 |